Advancements in Reprogramming iPSC-Derived Stem Cell Therapy to Replace & Restore Degenerated RPE Cells in Late-Stage AMD
Time: 2:00 pm
day: Conference Day Two
Details:
- Exploring the latest advancements in using iPSCs to generate RPE cells for cell replacement therapy in late-stage AMD
- Discussing the process of reprogramming iPSCs into functional RPE cells and the challenges associated with ensuring their proper integration and functionality within the retina
- Presenting preclinical and clinical evidence supporting the safety and efficacy of iPSC-derived cell therapy in restoring retinal function and preserving vision in patients with advanced AMD
